Publications - Page 2 of 5 - HMI

“Bacterial DNA promotes tau and beta-amyloid aggregation and is suggested as a novel therapeutic target for Alzheimer’s disease” The Lancet Summit. December 14-16, 2021

New York, NY (December 16, 2022) – A New-York city-based Human Microbiology Institute presented “Bacterial DNA promotes tau and beta-amyloid aggregation and is suggested as a novel therapeutic target for Alzheimer’s disease” at the Lancet Summit: Presymptomatic Prevention and Treatment of Neurodegenerative Diseases.

SARS-CoV-2 Prion-Like Domains in Spike Proteins Enable Higher Affinity to ACE2

TBDL(2020)

Bacterial DNA promotes Tau aggregation

Scientific Reports (2020)

A new biological definition of life

Biomolecular Concepts (2020)

Bacterial DNA induces the formation of heat-resistant disease-associated proteins in human plasma

Scientific Reports (2019)

Type 1 Diabetes: an Association Between Autoimmunity, the Dynamics of Gut Amyloid-producing E. coli and Their Phages

Microbiology Resources and Announcements (2019)

Draft Genome Sequence of Streptococcus halitosis sp. nov., Isolated from the Dorsal Surface of the Tongue of a Patient with Halitosis

Microbiology Resources and Announcements (2019)

Tetz’s theory and law of longevity

Theories in Biosciences (2018)

Parkinson’s disease and bacteriophages as its overlooked contributors

Scientfic Reports (2018)

Bacteriophages as New Human Viral Pathogens

Microorganisms MDPI (2018)